Sexual dysfunction
3 papers
Trial sponsors
Company1 trialPhase 3358 people
University of Campania Luigi Vanvitelli
1 trialPhase 4300 people
1 trialPhase 4151 people
University of Alabama at Birmingham
1 trialPhase 438 people
1 trialPhase 34,236 people
University College London (UCL) Cancer Institute
1 trialPhase 34,236 people
Alliance for Clinical Trials in Oncology
1 trialPhase 3227 people
Funding
1 grant since 2026National Cancer InstituteUS$374.3k
Latest
6 in 12 monthsAvicenna Journal of Phytomedicine
Evaluation of the effects of Asparagus racemosus extract (ARova5X) supplementation on postmenopausal discomfort
Randomised trial in 214 peopleInterventions
International Journal of Gynecological Cancer
Hormone replacement therapy in gynecologic cancer survivors: bridging the gap between evidence and clinical practice
Post Reproductive Health
Evaluation of sexual function according to age in women referred to urogynaecology clinics
Cross-sectional study of 8,372 peoplePopulations
Translational Andrology and Urology
Effects of GLP-1 analogs on metabolic alterations including male sexual function, hypogonadism and erectile dysfunction: a narrative review
ReviewErectile dysfunction
ENDO 2025 Abstract
SAT-147 The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Erectile Dysfunction and Testosterone Levels: A Systematic Review and Meta-Analysis
Meta-analysis of studies in peopleGLP-1 receptor agonists
ENDO 2025 Abstract
SAT-819 What Kind of Specialists Should Know About Hormone Therapy?
ReviewInterventions
International Journal of Molecular Sciences
The Role of Testosterone in the Elderly: What Do We Know?
ReviewTestosterone